MitraClip NTR/XTR Clip Delivery System; MitraClip G4 System
ABBOTT MEDICAL · Decision date Mar 6, 2026
What did the FDA decide?
FDA records P100009/S083 as a supplement to PMA P100009, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 6, 2026.
FDA approval order statement
harmonization across preconditioning parameters in preconditioning cells at one sterilization facility, and implementation of sustainable reduced ethylene oxide sterilization cycles at two other sterilization facilities
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P100009/S083
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- NKM
- Decision code
- OK30
- Decision date
- Mar 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Mitral valve repair devices.
- Applicant
- Abbott Medical
- Product code
- NKM
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P100009/S077 · Related supplement
MitraClip G5 Delivery System
P100009/S079 · Related supplement
MitraClip Delivery System
P100009/S078 · Related supplement
MitraClip G5 Delivery System
P100009/S080 · Related supplement
MitraClip G4 Clip Delivery System; MitraClip G5 Delivery System
P100009/S081 · Related supplement
MITRACLIP DELIVERY SYSTEM
P100009/S083 received
Application receipt date recorded by FDA.
P100009/S082 · Related supplement
MitraClip G5 Delivery System (CDS0801-NT, CDS0801-NTW, CDS0801-XT, CDS0801-XTW)
P100009/S083 · FDA decision
30-Day Notice
P100009/S084 · Related supplement
MitraClip Systems
P100009/S085 · Related supplement
MitraClip Delivery Systems
P100009/S086 · Related supplement
MitraClip Systems
Timeline entries are records held by MedtechLedger for P100009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MitraClip G5 Delivery SystemP100009/S077 | ABBOTT MEDICAL | PMA supplement | Jul 23, 2025 | FDA |
MitraClip Delivery SystemP100009/S079 | ABBOTT MEDICAL | PMA supplement | Aug 18, 2025 | FDA |
MitraClip G5 Delivery SystemP100009/S078 | ABBOTT MEDICAL | PMA supplement | Aug 20, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2025 | FDA | |
MITRACLIP DELIVERY SYSTEMP100009/S081 | ABBOTT MEDICAL | PMA supplement | Oct 17, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 25, 2026 | FDA | |
MitraClip SystemsP100009/S084 | ABBOTT MEDICAL | PMA supplement | May 14, 2026 | FDA |
MitraClip Delivery SystemsP100009/S085 | ABBOTT MEDICAL | PMA supplement | May 28, 2026 | FDA |
MitraClip SystemsP100009/S086 | ABBOTT MEDICAL | PMA supplement | Jun 25, 2026 | FDA |
Explore the linked device profile
Other records with product code NKM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 9, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jun 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 177 County Rd. B E., St. Paul, MN, 55117
Sources and methodology
- Original FDA record: P100009/S083
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






